halothane has been researched along with alprostadil in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ikeda, K; Ikeda, T; Kazama, T; Kikura, M | 1 |
| Kawamoto, M; Suzuki, N; Takasaki, M | 1 |
| Aono, J; Hirakawa, M; Takeda, A; Ueda, W | 1 |
| Baretton, G; Heger, B; Siegers, CP; Younes, M | 1 |
| Coupar, IM | 1 |
| Baba, K; Fujii, S; Nagai, I; Sari, A; Yonei, A | 1 |
| Oda, T; Yoshimine, K; Yoshimura, N | 1 |
| Harukuni, I; Naito, H; Yamaguchi, H | 1 |
| Hoka, S; Kawasaki, T; Okamoto, H; Okuyama, T; Takahashi, S | 1 |
| Kumada, H; Tsubota, A | 1 |
1 review(s) available for halothane and alprostadil
| Article | Year |
|---|---|
[Emergency drug therapy of fulminant hepatitis].
Topics: Alprostadil; Amino Acids, Branched-Chain; Apoptosis; Cytokines; Emergencies; Halothane; Hepatic Encephalopathy; Hepatitis Viruses; Humans; Immunosuppressive Agents; Interferons; Plasma Exchange | 1995 |
12 other study(ies) available for halothane and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of prostaglandin E1 on myocardial contractility in dogs anesthetized with halothane: load-independent and noninvasive assessment using transesophageal echocardiography.
Topics: Alprostadil; Anesthesia, Inhalation; Animals; Blood Pressure; Dogs; Echocardiography; Esophagus; Female; Halothane; Heart Rate; Heart Ventricles; Infusions, Intravenous; Male; Myocardial Contraction; Papillary Muscles; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1992 |
Acute pulmonary edema after intravenous liquid halothane in dogs.
Topics: Alprostadil; Animals; Dogs; Glucuronidase; Halothane; Hemodynamics; Injections, Intravenous; Lipid Peroxides; Pulmonary Edema; Thromboxane B2 | 1992 |
[Interaction of halothane and PGE1 on ICG excretion].
Topics: Adult; Aged; Alprostadil; Anesthesia, Inhalation; Female; Halothane; Humans; Indocyanine Green; Liver Circulation; Male; Middle Aged | 1990 |
Inhibition of halothane-induced lipid peroxidation by misoprostol without hepatoprotection.
Topics: Acetaminophen; Alanine Transaminase; Alprostadil; Animals; Halothane; Hydrocarbons, Chlorinated; L-Iditol 2-Dehydrogenase; Lipid Peroxidation; Liver; Male; Mice; Misoprostol; Rats; Rats, Inbred Strains; Thioacetamide | 1988 |
Choice of anesthetic for intestinal absorption and secretion experiments using rats.
Topics: Alprostadil; Anesthetics; Animals; Body Water; Female; Glucose; Halothane; Intestinal Absorption; Intestinal Secretions; Male; Pentobarbital; Prostaglandins E; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide | 1985 |
[Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
Topics: Alprostadil; Anesthesia, Inhalation; Diazepam; Ductus Arteriosus, Patent; Female; Halothane; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Morphine; Prostaglandins E | 1984 |
[Clinical application of prostaglandin E1 for hypotensive anesthesia (author's transl)].
Topics: Adult; Alprostadil; Female; Halothane; Humans; Hypotension, Controlled; Infusions, Parenteral; Middle Aged; Nitrous Oxide; Prostaglandins E | 1981 |
Haemodynamic, diuretic and hormonal responses to prostaglandin E1 infusion in halothane anaesthetized dogs: comparison among epidural lidocaine, epidural fentanyl and epidural saline.
Topics: Alprostadil; Anesthesia, Epidural; Anesthesia, Inhalation; Animals; Blood Pressure; Creatinine; Diuresis; Dogs; Epinephrine; Fentanyl; Halothane; Hemodynamics; Hormones; Infusions, Intravenous; Laparotomy; Lidocaine; Renal Circulation; Sodium; Sodium Chloride; Urination; Vasopressins | 1995 |
Effects of phenylephrine and prostaglandin E1 on ventriculo-arterial matching during halothane anaesthesia.
Topics: Alprostadil; Anesthesia, General; Animals; Blood Pressure; Cardiac Output; Dogs; Drug Synergism; Female; Halothane; Heart; Heart Rate; Male; Myocardial Contraction; Phenylephrine; Vasodilator Agents | 1995 |